Company Intelligence
Foundation Medicine
MedTwenty Company Score 81Cancer Genomics · Cambridge, United States · Founded 2010
Comprehensive genomic profiling provider owned by Roche, and the principal competitor for NHS pathology network contracts.
Key facts
Employees1,600
RevenueNot separately reported
ValuationNot disclosed
Last roundWholly owned by Roche
Funding history
| Date | Round | Amount | Lead investor |
|---|
Timeline
- 26 Sep 2026Competitive position reset by Tempus–Personalis transaction.
Benchmarks, competitor comparison and export
Professional membership unlocks side-by-side competitor comparison, historical financial series and CSV export for this company.
Upgrade